Skip to main content
Erschienen in: Inflammation Research 12/2016

30.08.2016 | Original Research Paper

Subset-specific alterations in frequencies and functional signatures of γδ T cells in systemic sclerosis patients

verfasst von: Ana Henriques, Cláudia Silva, Mariana Santiago, Maria João Henriques, António Martinho, Hélder Trindade, José António Pereira da Silva, Bruno Silva-Santos, Artur Paiva

Erschienen in: Inflammation Research | Ausgabe 12/2016

Einloggen, um Zugang zu erhalten

Abstract

Objective and design

Here, we evaluated the distribution and functional profile of circulating CD27+ and CD27 γδ T-cell subsets in systemic sclerosis (SSc) patients to assess their potential role in this disorder.

Materials and methods

Peripheral blood from 39 SSc patients and 20 healthy individuals was used in this study. The TCR-γδ repertoire, cytokine production and cytotoxic signatures of circulating γδ T-cell subsets were assessed by flow cytometry. Gene expression of EOMES, NKG2D and GZMA was evaluated by quantitative RT-PCR in both purified γδ T-cell subsets.

Results

Absolute numbers of γδ T-cell subsets were significantly decreased in SSc groups, likely reflecting their mobilization to the inflamed skin. Both γδ T-cell subsets preserved their relative proportions and Th1-type cytokine responses. However, cytotoxic properties showed significant disease-associated and subset-specific changes. SSc patients exhibited increased percentages of CD27+ γδ T cells expressing granzyme B or perforin and upregulated GZMA expression in diffuse cutaneous SSc. Conversely, EOMES and NKG2D were downregulated in both SSc γδ T-cell subsets vs. normal controls. Interestingly, patients with pulmonary fibrosis showed a biased TCR repertoire, with a selected expansion of effector Vγ9+ γδ T cells associated with increased frequency of cells expressing granzyme B, but decreased IFN-γ production.

Conclusions

Significant alterations on circulating γδ T-cell subsets suggest a deregulated (increased) cytotoxic activity and thus enhanced pathogenic potential of CD27+ γδ T cells in SSc.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
2.
Zurück zum Zitat Gu YS, Kong J, Cheema GS, Keen CL, Wick G, Gershwin ME. The immunobiology of systemic sclerosis. Semin Arthritis Rheum. 2008;38:132–60.CrossRefPubMed Gu YS, Kong J, Cheema GS, Keen CL, Wick G, Gershwin ME. The immunobiology of systemic sclerosis. Semin Arthritis Rheum. 2008;38:132–60.CrossRefPubMed
3.
Zurück zum Zitat Domsic RT, Medsger TA Jr. Disease subsets in clinical practice. In: Varga J, Denton C, Wigley F, editors. Scleroderma: from pathogenesis to comprehensive management. New York: Springer; 2012. p. 45–52.CrossRef Domsic RT, Medsger TA Jr. Disease subsets in clinical practice. In: Varga J, Denton C, Wigley F, editors. Scleroderma: from pathogenesis to comprehensive management. New York: Springer; 2012. p. 45–52.CrossRef
4.
Zurück zum Zitat Chung L, Fransen J, van den Hoogen F. Evolving concepts of diagnosis and classification. In: Varga J, Denton C, Wigley F, editors. Scleroderma: from pathogenesis to comprehensive management. New York: Springer; 2012. p. 54–69. Chung L, Fransen J, van den Hoogen F. Evolving concepts of diagnosis and classification. In: Varga J, Denton C, Wigley F, editors. Scleroderma: from pathogenesis to comprehensive management. New York: Springer; 2012. p. 54–69.
5.
Zurück zum Zitat Tiev KP, Abriol J, Burland MC, Antonelli D, Klatzmann D, Cabane J, Boyer O. T cell repertoire in patients with stable scleroderma. Clin Exp Immunol. 2005;139:348–54.CrossRefPubMedPubMedCentral Tiev KP, Abriol J, Burland MC, Antonelli D, Klatzmann D, Cabane J, Boyer O. T cell repertoire in patients with stable scleroderma. Clin Exp Immunol. 2005;139:348–54.CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Fuschiotti P, Larregina AT, Ho J, Feghali-Bostwick C, Medsger TA Jr. Interleukin-13-producing CD8 + T cells mediate dermal fibrosis in patients with systemic sclerosis. Arthritis Rheum. 2013;65:236–46.CrossRefPubMedPubMedCentral Fuschiotti P, Larregina AT, Ho J, Feghali-Bostwick C, Medsger TA Jr. Interleukin-13-producing CD8 + T cells mediate dermal fibrosis in patients with systemic sclerosis. Arthritis Rheum. 2013;65:236–46.CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Stummvoll GH, Aringer M, Grisar J, Steiner CW, Smolen JS, Knobler R, Graninger WB. Increased transendothelial migration of scleroderma lymphocytes. Ann Rheum Dis. 2004;63:569–74.CrossRefPubMedPubMedCentral Stummvoll GH, Aringer M, Grisar J, Steiner CW, Smolen JS, Knobler R, Graninger WB. Increased transendothelial migration of scleroderma lymphocytes. Ann Rheum Dis. 2004;63:569–74.CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Holcombe RF, Baethge BA, Wolf RE, Betzing KW, Stewart RM. Natural killer cells and γδ T-cells in scleroderma: relationship to disease duration and anti-Scl-70 antibodies. Ann Rheum Dis. 1995;54:69–72.CrossRefPubMedPubMedCentral Holcombe RF, Baethge BA, Wolf RE, Betzing KW, Stewart RM. Natural killer cells and γδ T-cells in scleroderma: relationship to disease duration and anti-Scl-70 antibodies. Ann Rheum Dis. 1995;54:69–72.CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Giacomelli R, Matucci-Cerinic M, Cipriani P, Ghersetich I, Lattanzio R, Pavan A, Pignone A, Cagnoni ML, Lotti T, Tonietti G. Circulating Vdelta1+ T cells are activated and accumulate in the skin of systemic sclerosis patients. Arthritis Rheum. 1998;41:327–34.CrossRefPubMed Giacomelli R, Matucci-Cerinic M, Cipriani P, Ghersetich I, Lattanzio R, Pavan A, Pignone A, Cagnoni ML, Lotti T, Tonietti G. Circulating Vdelta1+ T cells are activated and accumulate in the skin of systemic sclerosis patients. Arthritis Rheum. 1998;41:327–34.CrossRefPubMed
11.
Zurück zum Zitat Born WK, O’Brien RL. γδ T cells develop, respond and survive—with a little help from CD27. Eur J Immunol. 2011;41:26–8.CrossRefPubMed Born WK, O’Brien RL. γδ T cells develop, respond and survive—with a little help from CD27. Eur J Immunol. 2011;41:26–8.CrossRefPubMed
12.
Zurück zum Zitat Ribot JC, deBarros A, Pang DJ, Neves JF, Peperzak V, Roberts SJ, Girardi M, Borst J, Hayday AC, Pennington DJ, Silva-Santos B. CD27 is a thymic determinant of the balance between interferon-gamma- and interleukin-17-producing gammadelta T cell subsets. Nat Immunol. 2009;10:427–36.CrossRefPubMedPubMedCentral Ribot JC, deBarros A, Pang DJ, Neves JF, Peperzak V, Roberts SJ, Girardi M, Borst J, Hayday AC, Pennington DJ, Silva-Santos B. CD27 is a thymic determinant of the balance between interferon-gamma- and interleukin-17-producing gammadelta T cell subsets. Nat Immunol. 2009;10:427–36.CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Ribot JC, Chaves-Ferreira M, d’Orey F, Wencker M, Goncalves-Sousa N, Decalf J, Simas JP, Hayday AC, Silva-Santos B. Cutting edge: adaptive versus innate receptor signals selectively control the pool sizes of murine IFN-gamma or IL-17-producing gammadelta T cells upon infection. J Immunol. 2010;185:6421–5.CrossRefPubMedPubMedCentral Ribot JC, Chaves-Ferreira M, d’Orey F, Wencker M, Goncalves-Sousa N, Decalf J, Simas JP, Hayday AC, Silva-Santos B. Cutting edge: adaptive versus innate receptor signals selectively control the pool sizes of murine IFN-gamma or IL-17-producing gammadelta T cells upon infection. J Immunol. 2010;185:6421–5.CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Dieli F, Poccia F, Lipp M, Sireci G, Caccamo N, Salerno A. Differentiation of effector/memory Vdelta2 T cells and migratory routes in lymph nodes or inflammatory sites. J Exp Med. 2003;198:391–7.CrossRefPubMedPubMedCentral Dieli F, Poccia F, Lipp M, Sireci G, Caccamo N, Salerno A. Differentiation of effector/memory Vdelta2 T cells and migratory routes in lymph nodes or inflammatory sites. J Exp Med. 2003;198:391–7.CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat DeBarros A, Chaves-Ferreira M, d’Orey F, Ribot JC, Silva-Santos B. CD70-CD27 interactions provide survival and proliferative signals that regulate T-cell receptor-driven activation of human gamma-delta peripheral blood lymphocytes. Eur J Immunol. 2011;41:195–201.CrossRefPubMed DeBarros A, Chaves-Ferreira M, d’Orey F, Ribot JC, Silva-Santos B. CD70-CD27 interactions provide survival and proliferative signals that regulate T-cell receptor-driven activation of human gamma-delta peripheral blood lymphocytes. Eur J Immunol. 2011;41:195–201.CrossRefPubMed
16.
Zurück zum Zitat ARA. Subcommittee for scleroderma criteria of the american rheumatism association diagnostic and therapeutic criteria committee. preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum. 1980;23:581–90.CrossRef ARA. Subcommittee for scleroderma criteria of the american rheumatism association diagnostic and therapeutic criteria committee. preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum. 1980;23:581–90.CrossRef
17.
Zurück zum Zitat LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA Jr, Rowell N, Wollheim F. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol. 1988;15:202–5.PubMed LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA Jr, Rowell N, Wollheim F. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol. 1988;15:202–5.PubMed
18.
Zurück zum Zitat Henriques A, Inês L, Pais ML, da Silva JP, Paiva A. Th17 cells in systemic lupus erythematosus share functional features with Th17 cells from normal bone marrow and peripheral tissues. Clin Rheumatol. 2012;31:483–91.CrossRefPubMed Henriques A, Inês L, Pais ML, da Silva JP, Paiva A. Th17 cells in systemic lupus erythematosus share functional features with Th17 cells from normal bone marrow and peripheral tissues. Clin Rheumatol. 2012;31:483–91.CrossRefPubMed
19.
Zurück zum Zitat Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, Speleman F. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 2002;3:research0034.1–11.CrossRef Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, Speleman F. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 2002;3:research0034.1–11.CrossRef
20.
Zurück zum Zitat Riccieri V, Parisi G, Spadaro A, Scrivo R, Barone F, Moretti T, Bernardini G, Strom R, Taccari E, Valesini G. Reduced circulating natural killer T cells and gamma/delta T cells in patients with systemic sclerosis. J Rheumatol. 2005;32:283–6.PubMed Riccieri V, Parisi G, Spadaro A, Scrivo R, Barone F, Moretti T, Bernardini G, Strom R, Taccari E, Valesini G. Reduced circulating natural killer T cells and gamma/delta T cells in patients with systemic sclerosis. J Rheumatol. 2005;32:283–6.PubMed
21.
Zurück zum Zitat Bendersky A, Markovits N, Bank I. Vgamma9 + gammadelta T cells in systemic sclerosis patients are numerically and functionally preserved and induce fibroblast apoptosis. Immunobiology. 2010;215:380–94.CrossRefPubMed Bendersky A, Markovits N, Bank I. Vgamma9 + gammadelta T cells in systemic sclerosis patients are numerically and functionally preserved and induce fibroblast apoptosis. Immunobiology. 2010;215:380–94.CrossRefPubMed
22.
Zurück zum Zitat Qin G, Mao H, Zheng J, Sia SF, Liu Y, Chan PL, Lam KT, Peiris JS, Lau YL, Tu W. Phosphoantigen-expanded human gammadelta T cells display potent cytotoxicity against monocyte-derived macrophages infected with human and avian influenza viruses. J Infect Dis. 2009;200:858–65.CrossRefPubMed Qin G, Mao H, Zheng J, Sia SF, Liu Y, Chan PL, Lam KT, Peiris JS, Lau YL, Tu W. Phosphoantigen-expanded human gammadelta T cells display potent cytotoxicity against monocyte-derived macrophages infected with human and avian influenza viruses. J Infect Dis. 2009;200:858–65.CrossRefPubMed
23.
Zurück zum Zitat Zhu P, Martinvalet D, Chowdhury D, Zhang D, Schlesinger A, Lieberman J. The cytotoxic T lymphocyte protease granzyme A cleaves and inactivates poly(adenosine 5′-diphosphate-ribose) polymerase-1. Blood. 2009;114:1205–16.CrossRefPubMedPubMedCentral Zhu P, Martinvalet D, Chowdhury D, Zhang D, Schlesinger A, Lieberman J. The cytotoxic T lymphocyte protease granzyme A cleaves and inactivates poly(adenosine 5′-diphosphate-ribose) polymerase-1. Blood. 2009;114:1205–16.CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Casciola-Rosen L, Andrade F, Ulanet D, Wong WB, Rosen A. Cleavage by granzyme B is strongly predictive of autoantigen status: implications for initiation of autoimmunity. J Exp Med. 1999;190:815–26.CrossRefPubMedPubMedCentral Casciola-Rosen L, Andrade F, Ulanet D, Wong WB, Rosen A. Cleavage by granzyme B is strongly predictive of autoantigen status: implications for initiation of autoimmunity. J Exp Med. 1999;190:815–26.CrossRefPubMedPubMedCentral
25.
Zurück zum Zitat Oppenheim DE, Roberts SJ, Clarke SL, Filler R, Lewis JM, Tigelaar RE, Girardi M, Hayday AC. Sustained localized expression of ligand for the activating NKG2D receptor impairs natural cytotoxicity in vivo and reduces tumor immunosurveillance. Nat Immunol. 2005;6:928–37.CrossRefPubMed Oppenheim DE, Roberts SJ, Clarke SL, Filler R, Lewis JM, Tigelaar RE, Girardi M, Hayday AC. Sustained localized expression of ligand for the activating NKG2D receptor impairs natural cytotoxicity in vivo and reduces tumor immunosurveillance. Nat Immunol. 2005;6:928–37.CrossRefPubMed
26.
Zurück zum Zitat Intlekofer AM, Banerjee A, Takemoto N, Gordon SM, Dejong CS, Shin H, Hunter CA, Wherry EJ, Lindsten T, Reiner SL. Anomalous type 17 response to viral infection by CD8 T cells lacking T-bet and eomesodermin. Science. 2008;321:408–11.CrossRefPubMedPubMedCentral Intlekofer AM, Banerjee A, Takemoto N, Gordon SM, Dejong CS, Shin H, Hunter CA, Wherry EJ, Lindsten T, Reiner SL. Anomalous type 17 response to viral infection by CD8 T cells lacking T-bet and eomesodermin. Science. 2008;321:408–11.CrossRefPubMedPubMedCentral
27.
Zurück zum Zitat Pearce EL, Mullen AC, Martins GA, Krawczyk CM, Hutchins AS, Zediak VP, Banica M, DiCioccio CB, Gross DA, Mao CA, Shen H, Cereb N, Yang SY, Lindsten T, Rossant J, Hunter CA, Reiner SL. Control of effector CD8 T cell function by the transcription factor Eomesodermin. Science. 2003;302:1041–3.CrossRefPubMed Pearce EL, Mullen AC, Martins GA, Krawczyk CM, Hutchins AS, Zediak VP, Banica M, DiCioccio CB, Gross DA, Mao CA, Shen H, Cereb N, Yang SY, Lindsten T, Rossant J, Hunter CA, Reiner SL. Control of effector CD8 T cell function by the transcription factor Eomesodermin. Science. 2003;302:1041–3.CrossRefPubMed
28.
Zurück zum Zitat Banerjee A, Gordon SM, Intlekofer AM, Paley MA, Mooney EC, Lindsten T, Wherry EJ, Reiner SL. Cutting edge: the transcription factor eomesodermin enables CD8 T cells to compete for the memory cell niche. J Immunol. 2010;185:4988–92.CrossRefPubMedPubMedCentral Banerjee A, Gordon SM, Intlekofer AM, Paley MA, Mooney EC, Lindsten T, Wherry EJ, Reiner SL. Cutting edge: the transcription factor eomesodermin enables CD8 T cells to compete for the memory cell niche. J Immunol. 2010;185:4988–92.CrossRefPubMedPubMedCentral
29.
Zurück zum Zitat Rao RR, Li Q, Odunsi K, Shrikant PA. The mTOR kinase determines effector versus memory CD8 T cell fate by regulating the expression of transcription factors T-bet and Eomesodermin. Immunity. 2010;32:67–78.CrossRefPubMed Rao RR, Li Q, Odunsi K, Shrikant PA. The mTOR kinase determines effector versus memory CD8 T cell fate by regulating the expression of transcription factors T-bet and Eomesodermin. Immunity. 2010;32:67–78.CrossRefPubMed
31.
Zurück zum Zitat Champagne E. γδ T cell receptor ligands and modes of antigen recognition. Arch Immunol Ther Exp (Warsz). 2011;59:117–37 (Review).CrossRef Champagne E. γδ T cell receptor ligands and modes of antigen recognition. Arch Immunol Ther Exp (Warsz). 2011;59:117–37 (Review).CrossRef
Metadaten
Titel
Subset-specific alterations in frequencies and functional signatures of γδ T cells in systemic sclerosis patients
verfasst von
Ana Henriques
Cláudia Silva
Mariana Santiago
Maria João Henriques
António Martinho
Hélder Trindade
José António Pereira da Silva
Bruno Silva-Santos
Artur Paiva
Publikationsdatum
30.08.2016
Verlag
Springer International Publishing
Erschienen in
Inflammation Research / Ausgabe 12/2016
Print ISSN: 1023-3830
Elektronische ISSN: 1420-908X
DOI
https://doi.org/10.1007/s00011-016-0982-6

Weitere Artikel der Ausgabe 12/2016

Inflammation Research 12/2016 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Reizdarmsyndrom: Diäten wirksamer als Medikamente

29.04.2024 Reizdarmsyndrom Nachrichten

Bei Reizdarmsyndrom scheinen Diäten, wie etwa die FODMAP-arme oder die kohlenhydratreduzierte Ernährung, effektiver als eine medikamentöse Therapie zu sein. Das hat eine Studie aus Schweden ergeben, die die drei Therapieoptionen im direkten Vergleich analysierte.

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.